HFS
LUCD icon

Hantz Financial Services’s Lucid Diagnostics LUCD Stock Holding History

Hantz Financial Services’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10
Closed – – 1165
2024
Q3 		$0 Hold
10
– – ﹤0.01% 1141
2024
Q2 		$0 Hold
10
– – ﹤0.01% 1188
2024
Q1 		$0 Hold
10
– – ﹤0.01% 1258
2023
Q4 		$0 Hold
10
– – ﹤0.01% 1188
2023
Q3 		$0 Hold
10
– – ﹤0.01% 1158
2023
Q2 		$0 Hold
10
– – ﹤0.01% 1139
2023
Q1 		$0 Hold
10
– – ﹤0.01% 1167
2022
Q4 		$0 Hold
10
– – ﹤0.01% 1127
2022
Q3 		$0 Hold
10
– – ﹤0.01% 1115
2022
Q2 		$0 Buy
+10
New +$22 ﹤0.01% 1087

Other funds holding LUCD

LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hantz Financial Services's LUCD Position: Q4 2024 in Review

Hantz Financial Services sold out of Lucid Diagnostics (LUCD) in Q4 2024, closing a stake of 10 shares.

Hantz Financial Services first reported a position in LUCD in Q2 2022 and held it in 10 quarters. The position peaked at $0 in Q3 2024. 33 funds tracked by Wall St. Rank hold LUCD as of Q4 2024.

  • Hantz Financial Services reported no remaining Lucid Diagnostics position as of Q4 2024 after selling out during the quarter.
  • Hantz Financial Services sold 10 Lucid Diagnostics shares in Q4 2024.
  • Hantz Financial Services first reported a position in Lucid Diagnostics in Q2 2022 and held it in 10 quarters.
  • Hantz Financial Services's Lucid Diagnostics position peaked at $0 in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q4 2024.

Based on Hantz Financial Services's 13F filing for Q4 2024, filed 23 Jan 2025.